AXISBANK vs DRREDDY: Stock Comparison

Axis Bank Ltd vs Dr Reddys Laboratories LtdUpdated 12 August 2026, 4:08 PM ISTNSE & company filings

Axis Bank Ltd is the larger company by market capitalisation. Axis Bank Ltd shows a lower P/E, a higher ROE and faster revenue growth, while Dr Reddys Laboratories Ltd shows a higher dividend yield and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AXISBANK leads 10; DRREDDY leads 2 of 12

Not a rating
These companies operate in different sectors (Financial Services vs Healthcare). Valuation and leverage norms differ across sectors, so cross-sector ratio comparisons can mislead — compare each against its own sector peers too.

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AXISBANKDRREDDY

Valuation lens

What price are you paying?

Market CapContext only
AXISBANK
₹3.81 L Cr
DRREDDY
₹1 L Cr
P/E RatioAXISBANK has the lower reading
AXISBANK
13.72x
DRREDDY
31.05x
P/B RatioAXISBANK has the lower reading
AXISBANK
1.78x
DRREDDY
2.64x
EPSAXISBANK has the higher reading
AXISBANK
₹87.56
DRREDDY
₹41.33
Book ValueContext only
AXISBANK
₹717.55
DRREDDY
₹460.31
Dividend YieldDRREDDY has the higher reading
AXISBANK
0.08%
DRREDDY
0.69%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
AXISBANK is the larger company
₹3.81 L Cr vs ₹1 L Cr
P/E Ratio
AXISBANK has a lower P/E
13.72x vs 31.05x
P/B Ratio
AXISBANK has a lower P/B
1.78x vs 2.64x
EPS
AXISBANK has higher earnings per share
₹87.56 vs ₹41.33
Dividend Yield
DRREDDY has a higher dividend yield
0.69% vs 0.08%
Revenue Growth (TTM YoY)
AXISBANK has faster revenue growth
-11.2% vs -11.6%
EPS Growth (TTM YoY)
AXISBANK has faster EPS growth
6.4% vs -86.2%
Qtr Sales Growth
AXISBANK has stronger quarterly sales growth
5.3% vs -11.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAXISBANKDRREDDY
SectorFinancial ServicesHealthcare
IndustryPrivate Sector BankPharmaceuticals

Price

MetricAXISBANKDRREDDY
Live Price₹1,230₹1,200
Day Change0.02%-0.41%
Volume72.19 L23.67 L
52-Week High₹1,418.3₹1,414.9
52-Week Low₹1,042.5₹1,101
Distance from 52W High-13.28%-15.19%

Valuation

MetricAXISBANKDRREDDY
Market Cap₹3.81 L Cr₹1 L Cr
P/E Ratio13.72x31.05x
P/B Ratio1.78x2.64x
EPS₹87.56₹41.33
Book Value₹717.55₹460.31
Dividend Yield0.08%0.69%

Growth

MetricAXISBANKDRREDDY
Revenue Growth (TTM YoY)-11.2%-11.6%
EPS Growth (TTM YoY)6.4%-86.2%
Qtr Sales Growth5.3%-11.5%
Qtr Profit Growth1.71%-86.1%

Profitability & Leverage

Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.
MetricAXISBANKDRREDDY
ROE13.1%11.2%
ROCE6.24%13%
Net Margin32.13%12.76%
Operating Margin59.3%19.2%
Debt to Equity7.51x0.2x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAXISBANKDRREDDY
Promoter Holding7.87% 0.27 pp26.64% 0.01 pp
FII Holding43% 0.95 pp32.07% 1.01 pp
DII Holding42.69% 0.67 pp31.74% 1.02 pp
Public Holding6.43% 0.02 pp9.35% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Axis Bank Ltd and Dr Reddys Laboratories Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.